Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Does Brittany Maynard’s decision affect the future of oncology?

Ashley Sumrall, MD
Physician
November 8, 2014
Share
Tweet
Share

brittany-maynard

Would you base a life or death decision based on one doctor’s opinion? One research article? Google searches? What would it take?

I recently read that Brittany Maynard took her own life. Plagued by glioblastoma, she chose to reject chemotherapy, radiation, and hospice. Tomorrow, I have a schedule packed with glioblastoma patients who personify courage, determination, and faith.

Glioblastoma (GBM) is a primary brain cancer that spreads along the “glue” of the brain, destroying healthy brain and stealing function as it grows. It is one of the worst diagnoses in all of oncology to receive, as it is always terminal. As a neuro-oncologist, it is my “bread and butter” disease.

As I have followed her story, I have so many questions. I wonder what she was told by her doctors. She states that she visited with “many experts.”

Yes, GBM is a terminal illness. Yes, GBM is a terrible disease filled with suffering. But it is a diverse disease. Depending on which part of the brain is affected, patients may have minor or major neurologic deficits. As an outsider looking in, Brittany appeared to have no paralysis, muscle weakness, or language issues. A rapidly growing brain tumor usually causes at least one of these problems. I can’t seem to resolve this dichotomy between the pictures painted by her words and the pictures shared of her at the Grand Canyon.

Also, as physicians, we are often wrong when asked the dreaded “how long do I have to live” question. If you corner an oncologist, the most honest one will tell you they don’t know. Many will quote “six months or less” for most stage IV or grade IV cancers. Often, this answer is based less on evidence and more on the need to end a difficult conversation. Each individual’s course is so different with cancer. We are particularly poor at predicting survival for young patients. Just because a study showed a median overall survival value, it doesn’t always apply. For glioblastoma, we know that age and neurologic function matter. She appeared to have both on her side.

And, more importantly, how much time did her doctors spend with her? In an era where physician visits grow shorter and shorter, were they watching the clock or the patient? Was she being squeezed in for a consultation? Did they know the impact of their words would be so large? Did Brittany know the truth about chemotherapy and radiation for this disease, as the side effects are vastly different than those from the omnipresent breast cancer? Was she cognitively impaired by her illness, and did she fully understand? Was she worried about disappointing those who viewed her as a role model for assisted suicide?

I know nothing of her case, but I know this: I have seen people live for years with treatment. And the end is hard, but not usually painful. Suffering can always be diminished with properly trained physicians and nurses. Brain tumor patients require and deserve every resource available. The families that I have cared for have been remarkably grateful for the extra time I have spent with them, discussing death, palliation, and faith. In this field, it is not only necessary but essential.

I fear that more cancer patients will seek out assisted suicide as an option due to fear of the unknown. Many will have a myopic view of their cancer or therapy options due to misinformation from their care teams or the Internet. Their decisions may be colored by the fear of death and dying that pervades our society. Is this where oncology is headed? I pray not.

Ashley Sumrall is a neuro-oncologist.

Prev

What’s your physician digital health innovator type?

November 8, 2014 Kevin 2
…
Next

Every physician is public and has an audience

November 8, 2014 Kevin 3
…

Tagged as: Oncology/Hematology, Palliative Care

Post navigation

< Previous Post
What’s your physician digital health innovator type?
Next Post >
Every physician is public and has an audience

ADVERTISEMENT

More by Ashley Sumrall, MD

  • My colleagues are nervous. My patients are crying. And yet, we are here.

    Ashley Sumrall, MD
  • 10 lessons from Hamilton that made me a better oncologist

    Ashley Sumrall, MD
  • When anyone can be a cancer doctor

    Ashley Sumrall, MD

More in Physician

  • Finding meaning in medicine through the lens of Scarlet Begonias

    Arthur Lazarus, MD, MBA
  • Profit vs. patients in the U.S. health care system

    Banu Symington, MD
  • Why medicine needs military-style leadership and reconnaissance

    Ronald L. Lindsay, MD
  • Psychiatrists are physicians: a key distinction

    Farid Sabet-Sharghi, MD
  • Why we can’t forget public health

    Ryan McCarthy, MD
  • Why pediatric leadership fails without logistics and tactics

    Ronald L. Lindsay, MD
  • Most Popular

  • Past Week

    • The loss of community pharmacy expertise

      Muhammad Abdullah Khan | Conditions
    • Accountable care cooperatives: a community-owned health care fix

      David K. Cundiff, MD | Policy
    • Psychiatrists are physicians: a key distinction

      Farid Sabet-Sharghi, MD | Physician
    • Why the expiration of ACA enhanced subsidies threatens health care access

      Sandya Venugopal, MD and Tina Bharani, MD | Policy
    • Why learning specialists are central to medical education [PODCAST]

      The Podcast by KevinMD | Podcast
    • A physician’s tribute to his medical technologist wife

      Ronald L. Lindsay, MD | Physician
  • Past 6 Months

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Patient modesty in health care matters

      Misty Roberts | Conditions
    • The U.S. gastroenterologist shortage explained

      Brian Hudes, MD | Physician
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
  • Recent Posts

    • Why learning specialists are central to medical education [PODCAST]

      The Podcast by KevinMD | Podcast
    • Finding meaning in medicine through the lens of Scarlet Begonias

      Arthur Lazarus, MD, MBA | Physician
    • Profit vs. patients in the U.S. health care system

      Banu Symington, MD | Physician
    • How to keep the soul of medicine alive in a scaling system

      Gerald Kuo | Conditions
    • Why medicine needs military-style leadership and reconnaissance

      Ronald L. Lindsay, MD | Physician
    • How to handle medical gaslighting

      Alan P. Feren, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 45 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The loss of community pharmacy expertise

      Muhammad Abdullah Khan | Conditions
    • Accountable care cooperatives: a community-owned health care fix

      David K. Cundiff, MD | Policy
    • Psychiatrists are physicians: a key distinction

      Farid Sabet-Sharghi, MD | Physician
    • Why the expiration of ACA enhanced subsidies threatens health care access

      Sandya Venugopal, MD and Tina Bharani, MD | Policy
    • Why learning specialists are central to medical education [PODCAST]

      The Podcast by KevinMD | Podcast
    • A physician’s tribute to his medical technologist wife

      Ronald L. Lindsay, MD | Physician
  • Past 6 Months

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Patient modesty in health care matters

      Misty Roberts | Conditions
    • The U.S. gastroenterologist shortage explained

      Brian Hudes, MD | Physician
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
  • Recent Posts

    • Why learning specialists are central to medical education [PODCAST]

      The Podcast by KevinMD | Podcast
    • Finding meaning in medicine through the lens of Scarlet Begonias

      Arthur Lazarus, MD, MBA | Physician
    • Profit vs. patients in the U.S. health care system

      Banu Symington, MD | Physician
    • How to keep the soul of medicine alive in a scaling system

      Gerald Kuo | Conditions
    • Why medicine needs military-style leadership and reconnaissance

      Ronald L. Lindsay, MD | Physician
    • How to handle medical gaslighting

      Alan P. Feren, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Does Brittany Maynard’s decision affect the future of oncology?
45 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...